Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
258 0 |
Căutarea după subiecte similare conform CZU |
616.24-053.31-092-071 (1) |
Pathology of the respiratory system. Complaints of the respiratory organs (777) |
SM ISO690:2012 SĂRĂTURĂ, Valeria. Pulmonary alveoli: morphological, functional, and clinical aspects in premature children. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 30. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 616.24-053.31-092-071 | ||||||
Pag. 30-30 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
medical and social problems in the world. In addition, high mortality due to respiratory disorders is one of the major causes of prematurity. Objective of the study. To study the incidence, stages, treatment, and prevention of respiratory pathologies associated with alveolar growth in preterm infants. Material and Methods. A study of scientific articles on the topic. Results. Normal lung development consists of 6 phases, including postnatal development. Alveolocytes begin to appear in the canalicular phase, which ends about 26 weeks of gestation and is characterized by capillary development and subsequent differentiation of alveolocytes type I and II from undifferentiated epithelial cells. These processes occur under the influence of VEGF (Vascular Endothelial Growth Factor). Inhibition of vascular growth directly affects both vascularization and formation of alveoli, which in turn leads to surfactant deficiency, causing a number of lung diseases that may affect the life of the child in the future. Conclusion. Prevention of alveolar malformations is avoidance of premature birth, optimization of conditions of care for these children in the postnatal period, detection, monitoring, and treatment of the active phase of the pathology resulting from prematurity, with subsequent dispensing and social rehabilitation of these children. |
||||||
Cuvinte-cheie alveolocytes type I and II, prematurity, surfactant, prophylaxis, alveolocite de tip I și II, prematuri, surfactant, profilaxie |
||||||
|